Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 22
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
AnaptysBio Inc
ANAB
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$47.97
0.03
0.06%
Dern. MÀJ: Oct 22, 10:56 AM
$47.60
-0.34
-0.71%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Privacy Manager
AnaptysBio Financials
AnaptysBio (ANAB) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.46) by 76.09 percent. This is a 91.79 percent increase over losses of $(1.34) per share from the
Benzinga Newsdesk
PRO
AnaptysBio Q1 EPS $(1.84) Misses $(0.92) Estimate, Sales $25.556M Miss $28.973M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(0.92) by 100 percent. This is a 43.75 percent decrease over losses of $(1.28) per share from the
Benzinga Newsdesk
PRO
CORRECTION: AnaptysBio Q4 EPS $1.58 Beats $0.80 Estimate, Sales $108.240M Beat $92.051M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $1.58 per share which beat the analyst consensus estimate of $0.80 by 98.49 percent. This is a 319.44 percent increase over losses of $(0.72) per share from the
Benzinga Newsdesk
PRO
AnaptysBio Q3 EPS $0.52 Beats $(1.42) Estimate, Sales $76.320M Beat $15.811M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $(1.42) by 136.65 percent. This is a 145.61 percent increase over losses of $(1.14) per share from the
Benzinga Newsdesk
PRO
AnaptysBio Q2 EPS $(1.34) Beats $(1.52) Estimate, Sales $22.263M Beat $11.552M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(1.34) per share which beat the analyst consensus estimate of $(1.52) by 11.61 percent. This is a 21.64 percent increase over losses of $(1.71) per share from the
Benzinga Newsdesk
Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May
Avi Kapoor
